FDA Drug Application (021392) for CARDIZEM LA by VALEANT INTL

Back to FDA Applications sponsored by VALEANT INTL

Application Number021392
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage120MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARDIZEM LA
Active IngredientDILTIAZEM HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DILTIAZEM HYDROCHLORIDE11


Back to FDA Applications sponsored by VALEANT INTL